Neuroprotection Provided by Isoflurane Pre-Conditioning and Post-Conditioning

Ming Jiang,Liang Sun,Dong-xia Feng,Zheng-quan Yu,Rong Gao,Yuan-zhao Sun,Gang Chen
DOI: https://doi.org/10.4103/2045-9912.202910
2017-01-01
Medical Gas Research
Abstract:Isoflurane, a volatile and inhalational anesthetic, has been extensively used in perioperative period for several decades. A large amount of experimental studies have indicated that isoflurane exhibits neuroprotective properties when it is administrated before or after (pre-conditioning and post-conditioning) neurodegenerative diseases (e.g., hypoxic ischemia, stroke and trauma). Multiple mechanisms are involved in isoflurane induced neuroprotection, including activation of glycine and γ-aminobutyric acid receptors, antagonism of ionic channels and alteration of the function and activity of other cellular proteins. Although neuroprotection provided by isoflurane is observed in many animal studies, convincing evidence is lacking in human trials. Therefore, there is still a long way to go before translating its neuroprotective properties into clinical practice.
What problem does this paper attempt to address?